Articles | Anticoagulation Resource Center
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Comparison of the efficacy and safety of new oral anticoagulants
Dual Antiplatelet Therapy in Acute Transient Ischemic Attack and Minor Stroke
Apixaban
Apixaban for extended treatment of Venous Thromboembolism
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Apixaban with antiplatelet therapy after acute coronary syndrome
Apixaban in patients with atrial fibrillation
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement
Apixaban or enoxaparin for thromboprophylaxis after knee replacement
Apixaban in combination with antiplatelet therapy after ACS
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Atrial Fibrillation
A New Era for Anticoagulation in Atrial Fibrillation
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation
Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation
Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation
Dabigatran
Dabigatran etexilate: A novel oral direct thrombin inhibitor
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Dabigatran, Warfarin, or Placebo in VTE Dabigatran vs. placebo in ACS on dual antiplatelet therapy
Dabigatran vs. Warfarin in the Treatment of Acute Venous Thromboembolism
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
Heparin
Weight-based heparin protocol using antifactor Xa monitoring (AJHP)
Low-Molecular-Weight Heparin and Mortality in Acutely Ill Medical Patients
Practice Management
Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum
Implementing anticoagulation management by pharmacists in the inpatient setting
Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy
Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions
Effect of home testing of international normalized ratio on clinical events.
Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.
Anticoagulation management services: Entering a new era.
A method to determine the optimal intensity of oral anticoagulant therapy.
Pregnancy
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines Chest. 2012 Feb;141(2 Suppl):e691S-736S. doi: 10.1378/chest.11-2300.
Prevention and treatment of venous thromboembolism in pregnancy Clin Obstet Gynecol. 2012 Sep;55(3):774-87. doi: 10.1097/GRF.0b013e31825cfe7b.
Anticoagulation in pregnancy. Cardiol Clin. 2012 Aug;30(3):395-405. doi: 10.1016/j.ccl.2012.05.003.
Thrombosis in Pregnancy: Updates in diagnosis and management
Orthopedic Surgery
Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e278S-325S. doi: 10.1378/chest.11-2404.
Warfarin anticoagulation after total hip or total knee replacement: Clinical and resource-utilization outcomes in a university-based antithrombosis clinic. Am J Health Syst Pharm. 2013 Mar 1;70(5):423-30. doi: 10.2146/ajhp120341.
Advances in oral anticoagulation treatment: the safety and efficacy of rivaroxaban in the prevention and treatment of thromboembolism. Ther Adv Hematol. 2012 Oct;3(5):309-323.http://tah.sagepub.com/content/3/5/309.full.pdf+html
Implementation of a multidisciplinary, pharmacy-led, thromboprophylaxis program in total-joint arthroplasty patients
Rivaroxaban
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Rivaroxaban: An oral direct inhibitor of factor Xa
Rivaroxaban vs. Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
Rivaroxaban vs. Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
Venous Thromboembolism
New oral therapies for the prevention and treatment of venous thromboembolism
Emerging anticoagulants for venous thromboembolism prevention
Improving the quality of care for patients at risk for venous thromboembolism
Issues in assessing and reducing the risk for venous thromboembolism
Improving the quality of care for venous thromboembolism and acute coronary syndrome: Using evidence-based guidelines and performance measures
Prevention of VTE in patients having major orthopedic surgery
Aspirin for preventing the recurrence of venous thromboembolism
Thromboembolic prophylaxis in total joint arthroplasty (Thrombosis)
Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines
Clinical and management challenges in preventing venous thromboembolism in health systems: a case-based panel discussion
Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital
Warfarin
Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation Link
Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms
Drug-drug interactions between warfarin and psychotropics Link
Effect of Acetaminophen on International Normalized Ratio in Patients Receiving Warfarin Therapy
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Effect of Chronic Kidney Disease on Warfarin Management in a Pharmacist-Managed Anticoagulation Clinic
International Normalized Ratio values in group versus individual appointment in a pharmacist-managed anticoagulation clinic
Anticoagulation therapy for hospitalized patients: Patterns of use, compliance with national guidelines and performance on quality measures
Development and implementation of pharmacist-managed inpatient anticoagulation monitoring program
Impact of health disparities on staff workload in pharmacist-managed anticoagulation clinics
Articles | Anticoagulation Resource Center
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Comparison of the efficacy and safety of new oral anticoagulants
Dual Antiplatelet Therapy in Acute Transient Ischemic Attack and Minor Stroke
Apixaban
Apixaban for extended treatment of Venous Thromboembolism
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Apixaban with antiplatelet therapy after acute coronary syndrome
Apixaban in patients with atrial fibrillation
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement
Apixaban or enoxaparin for thromboprophylaxis after knee replacement
Apixaban in combination with antiplatelet therapy after ACS
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Atrial Fibrillation
A New Era for Anticoagulation in Atrial Fibrillation
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation
Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation
Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation
Dabigatran
Dabigatran etexilate: A novel oral direct thrombin inhibitor
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Dabigatran, Warfarin, or Placebo in VTE Dabigatran vs. placebo in ACS on dual antiplatelet therapy
Dabigatran vs. Warfarin in the Treatment of Acute Venous Thromboembolism
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
Heparin
Weight-based heparin protocol using antifactor Xa monitoring (AJHP)
Low-Molecular-Weight Heparin and Mortality in Acutely Ill Medical Patients
Practice Management
Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum
Implementing anticoagulation management by pharmacists in the inpatient setting
Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy
Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions
Effect of home testing of international normalized ratio on clinical events.
Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.
Anticoagulation management services: Entering a new era.
A method to determine the optimal intensity of oral anticoagulant therapy.
Pregnancy
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines Chest. 2012 Feb;141(2 Suppl):e691S-736S. doi: 10.1378/chest.11-2300.
Prevention and treatment of venous thromboembolism in pregnancy Clin Obstet Gynecol. 2012 Sep;55(3):774-87. doi: 10.1097/GRF.0b013e31825cfe7b.
Anticoagulation in pregnancy. Cardiol Clin. 2012 Aug;30(3):395-405. doi: 10.1016/j.ccl.2012.05.003.
Thrombosis in Pregnancy: Updates in diagnosis and management
Orthopedic Surgery
Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e278S-325S. doi: 10.1378/chest.11-2404.
Warfarin anticoagulation after total hip or total knee replacement: Clinical and resource-utilization outcomes in a university-based antithrombosis clinic. Am J Health Syst Pharm. 2013 Mar 1;70(5):423-30. doi: 10.2146/ajhp120341.
Advances in oral anticoagulation treatment: the safety and efficacy of rivaroxaban in the prevention and treatment of thromboembolism. Ther Adv Hematol. 2012 Oct;3(5):309-323.http://tah.sagepub.com/content/3/5/309.full.pdf+html
Implementation of a multidisciplinary, pharmacy-led, thromboprophylaxis program in total-joint arthroplasty patients
Rivaroxaban
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Rivaroxaban: An oral direct inhibitor of factor Xa
Rivaroxaban vs. Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
Rivaroxaban vs. Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
Venous Thromboembolism
New oral therapies for the prevention and treatment of venous thromboembolism
Emerging anticoagulants for venous thromboembolism prevention
Improving the quality of care for patients at risk for venous thromboembolism
Issues in assessing and reducing the risk for venous thromboembolism
Improving the quality of care for venous thromboembolism and acute coronary syndrome: Using evidence-based guidelines and performance measures
Prevention of VTE in patients having major orthopedic surgery
Aspirin for preventing the recurrence of venous thromboembolism
Thromboembolic prophylaxis in total joint arthroplasty (Thrombosis)
Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines
Clinical and management challenges in preventing venous thromboembolism in health systems: a case-based panel discussion
Pharmacist-led program to improve venous thromboembolism prophylaxis in a community hospital
Warfarin
Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation Link
Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms
Drug-drug interactions between warfarin and psychotropics Link
Effect of Acetaminophen on International Normalized Ratio in Patients Receiving Warfarin Therapy
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
Effect of Chronic Kidney Disease on Warfarin Management in a Pharmacist-Managed Anticoagulation Clinic
International Normalized Ratio values in group versus individual appointment in a pharmacist-managed anticoagulation clinic
Anticoagulation therapy for hospitalized patients: Patterns of use, compliance with national guidelines and performance on quality measures
Development and implementation of pharmacist-managed inpatient anticoagulation monitoring program
Impact of health disparities on staff workload in pharmacist-managed anticoagulation clinics
